ClinicalTrials.gg
RecruitingNCT05231265LOBAFRACSUpdated Jun 1, 2026

Effect of Lumbar Surgery on Complexity During a Walking Task in Chronic Low Back Pain

An observational study in Low Back Pain, sponsored by Centre Hospitalier Universitaire de Nīmes. Recruiting at 2 sites in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-06-01.

Sponsored by Centre Hospitalier Universitaire de Nīmes · Observational

How we know

From the registry’s dates

  • Started Oct 2023; still recruiting 3 years 1 month later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
32
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 12 studies in Low Back Pain by Centre Hospitalier Universitaire de Nīmes — 3 open to participants now, 3 under way, none of them phase 3. Low Back Pain · Centre Hospitalier Universitaire de Nīmes.

Started
2023
the only one that year
Observational
8 of 12
2 open now
Registered
9th of 12
by date

Among the 12 studies in Low Back Pain by Centre Hospitalier Universitaire de Nīmes, this one is the only one that started in 2023, is one of 8 observational ones, and was the 9th registered.

Low Back Pain

2,930 studies on the registry are indexed under Low Back Pain; 581 are open to participants now.

Browse Low Back Pain studies →

Open to participants now

3 of the 12 studies in Low Back Pain by Centre Hospitalier Universitaire de Nīmes are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 3 open studies →

Where they have run

Who these studies take

Of the 332 Low Back Pain studies recruiting now, 93 (28%) set no upper age limit and 209 (63%) stop at 75 or younger; 8 take children under 18; 46 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 12 studies in Low Back Pain by Centre Hospitalier Universitaire de Nīmes, or all of them as a file.
02

Study summary

Lumbar surgery is the most common treatment for chronic disabling low back pain with degenerative disc disease. There are few elements to objectively evaluate the improvement of the motor control after surgery and the motor adaptation capacities of the patients.

The impact of lumbar surgery on complexity in this painful context has never been studied. Theoretically, the restriction of mobility imposed by lumbar surgery should limit the subject's adaptive capacities (of one or more lumbar segments) and thus reduce complexity. Nevertheless, improvement in pain intensity levels could allow the patient to find better motor adaptation capacities, necessary for a positive evolution in the long-term.

The aim of this study was to investigate the evolution of gait complexity in chronic low back pain patients pre- and post-surgery. If surgery improves the adaptability of walking through an antalgic benefit exceeding the induced stiffness, the complexity of walking should be superior after surgery.

This is a proof-of-concept study in which the study investigators hypothesize that measuring complexity by fractal analysis during a walking task will show the increase in gait complexity induced by lumbar surgery at 3 and 6 months after surgery.

03

Conditions studied

  • Low Back Pain

Browse trials for

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients with chronic low back pain requiring prosthesis or arthrodesis surgery for their lumbar pathology (surgery on one or two levels) followed at the Nîmes University Hospital or at the Grand Sud Polyclinic.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients with chronic low back pain requiring prosthesis or arthrodesis surgery on one or two levels
  • Subject affiliated or beneficiary of a health insurance plan.
  • The patient must have given their free and

Exclusion criteria

Exclusion Criteria:

  • Patients with organic low back pain (infection, tumor, inflammatory rheumatism)
  • Patient with a neurological deficit (cauda equina syndrome or motor testing MRC \< 3 on a muscle group of the lower limbs)
  • Patient who has already undergone lumbar surgery (except single discectomy)
  • Patient with serious concomitant pathologies
  • Patients participating in a therapeutic study prohibiting participation in another study
  • Patient in an exclusion period from a different study
  • It is impossible to give the subject informed information
  • Patient is unable to express consent
  • The patient is under safeguard of justice or state guardianship
  • Patient is pregnant, parturient or breastfeeding
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
32 participants (estimated)
Patient registry
No

Groups and cohorts

  • Patients with Low Back Pain

    Other: Walking task

Interventions

  • OtherWalking task

    Treadmill walking task with study of fractal variability (complexity) for 10 minutes.

06

What researchers measure

Primary outcomes

  1. Gait complexity

    fractal analysis of gait variability: value normally between 0.5 (degraded structure) to 1 (optimal structure)

    Time frame: 10 days before surgery +/- 3 days

  2. Gait complexity

    fractal analysis of gait variability: value normally between 0.5 (degraded structure) to 1 (optimal structure)

    Time frame: Month 3

  3. Gait complexity

    fractal analysis of gait variability: value normally between 0.5 (degraded structure) to 1 (optimal structure)

    Time frame: Month 6

Secondary outcomes

  1. Patient reported pain

    Visual analog scale (0-100)

    Time frame: 10 days before surgery +/- 3 days

  2. Patient reported pain

    Visual analog scale (0-100)

    Time frame: Month 3

  3. Patient reported pain

    Visual analog scale (0-100)

    Time frame: Month 6

  4. Apprehension of pain of movement

    Tampa Scale of Kinesiophobia. Score ranging from 17-68. Higher scores denote greater level of kinesiophobia (a score \>40 is considered significant kinesiophobia)

    Time frame: 10 days before surgery +/- 3 days

  5. Apprehension of pain of movement

    Tampa Scale of Kinesiophobia. Score ranging from 17-68. Higher scores denote greater level of kinesiophobia (a score \>40 is considered significant kinesiophobia)

    Time frame: Month 3

  6. Apprehension of pain of movement

    Tampa Scale of Kinesiophobia. Score ranging from 17-68. Higher scores denote greater level of kinesiophobia (a score \>40 is considered significant kinesiophobia)

    Time frame: Month 6

  7. Patient reported quality of life

    EuroQol-5 Dimension questionnaire: results generated as 5 digit number corresponding to different aspects of quality of life

    Time frame: 10 days before surgery +/- 3 days

  8. Patient reported quality of life

    EuroQol-5 Dimension questionnaire: results generated as 5 digit number corresponding to different aspects of quality of life

    Time frame: Month 3

  9. Patient reported quality of life

    EuroQol-5 Dimension questionnaire: results generated as 5 digit number corresponding to different aspects of quality of life

    Time frame: Month 6

  10. Correlation between type of surgery and gait variability

    Classified as either arthrodesis or prosthesis

    Time frame: 10 days before surgery +/- 3 days

  11. Correlation between type of surgery and gait variability

    Classified as either arthrodesis or prosthesis

    Time frame: Month 3

  12. Correlation between type of surgery and gait variability

    Classified as either arthrodesis or prosthesis

    Time frame: Month 6

07

Study locations

1 of 2 sites recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Oct 2023 (actual). Primary completion is estimated for Apr 2027, 42 months after the start.

Of 177 non-industry observational studies under Low Back Pain, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 48. This study's planned 42 months is above that.

Counting every sponsor, half of 187 studies reached it within 24 months; a quarter within 10 and three quarters within 48.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 28, 2022
First posted
Feb 9, 2022
StartActual
Oct 16, 2023
Primary completionEst.
Apr 2027
CompletionEst.
Apr 2027
Last update
Jun 1, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 1, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05231265
Responsible party
Sponsor
First posted
Feb 9, 2022
Start date
Oct 16, 2023
Primary completion
Apr 2027 (estimated)
Completion
Apr 2027 (estimated)
Last update
Jun 1, 2026

Study contacts

Alexis Homs
Contact
alexis.homs@chu-nimes.fr
04.66.68.34.59
Alexis Homs
principal investigator · CHU Nimes

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion